FGD4 and prostate carcinoma: For example, expression of Frabin (FGD4), a GEF specific for Cdc42, positively correlates with the aggressive phenotype of prostate cancer and the tumor grade of pancreatic neuroendocrine neoplasms, most likely by maintaining abnormal activation of Cdc42 [60,61].